PAHR: Prognostic Marker in Severe Aortic Stenosis? - Summary - MDSpire

PAHR: Prognostic Marker in Severe Aortic Stenosis?

  • By

  • Julia Cipriano, MS, CMPP

  • June 27, 2026

  • 3 min

Share

Objective:

To evaluate the association of pressure-adjusted heart rate (PAHR) with survival in patients with severe aortic stenosis (AS).

Approach:
  • Study Design: A retrospective cohort study of 14,409 adult patients with severe native aortic stenosis identified via transthoracic echocardiography from 2010 to 2020.
  • PAHR Calculation: PAHR was calculated as heart rate × (right atrial pressure / mean arterial pressure) and patients were stratified into quartiles.
  • Survival Analysis: Kaplan-Meier analyses and multivariable Cox proportional hazards models were used to assess the association between PAHR and all-cause mortality.
Key Findings:
  • Higher PAHR quartiles were associated with progressively worse survival under medical management.
  • Patients in the second, third, and fourth PAHR quartiles had 15%, 61%, and 151% higher adjusted risks of mortality compared to the lowest quartile.
  • Baseline PAHR remained significantly associated with mortality following aortic valve replacement (AVR).
  • Patients in the third and fourth PAHR quartiles had 34% and 89% higher adjusted risks of mortality post-AVR.
Interpretation:

PAHR may provide a simple, noninvasive estimate of overall hemodynamic burden in severe AS, offering complementary insight into patient risk before and after valve replacement.

Limitations:
  • The study is retrospective and requires external validation.
  • Prospective studies are needed to assess the incremental value of serial PAHR assessment.
Conclusion:

PAHR should be viewed as complementary to existing risk assessment approaches rather than a replacement.

Sources:

Original Source(s)

Related Content